Tang, J., Qin, Y., Zhao, W., Tu, Y., & Sun, D. (2025). Abrocitinib alleviates the symptoms of Netherton syndrome and is well tolerated. Journal of Dermatological Treatment, 36(1), 1. https://doi.org/10.1080/09546634.2024.2447883
Chicago Style (17th ed.) CitationTang, Jun-Ting, Yu-Liang Qin, Wei-Jia Zhao, Ying Tu, and Dong-Jie Sun. "Abrocitinib Alleviates the Symptoms of Netherton Syndrome and Is Well Tolerated." Journal of Dermatological Treatment 36, no. 1 (2025): 1. https://doi.org/10.1080/09546634.2024.2447883.
MLA (9th ed.) CitationTang, Jun-Ting, et al. "Abrocitinib Alleviates the Symptoms of Netherton Syndrome and Is Well Tolerated." Journal of Dermatological Treatment, vol. 36, no. 1, 2025, p. 1, https://doi.org/10.1080/09546634.2024.2447883.